The recommended starting doses are as follows: For patients nave to basal insulin or to a GLP-1 RA, currently on less than 30 units of basal insulin, or on a GLP-1 RA: Start at 15 units subcutaneously once daily within 60 minutes of the first meal of the day
Rapid absorption
Finally, the development of dual GLP-1/GLP-2 receptor agonists, such as dapiglutide, has shown promise in reducing intestinal transit time and increasing villus height in murine models, representing an exciting future strategy (117)
* Mayor prdida de peso: Tambin ha mostrado una prdida de peso ms pronunciada en comparacin con los agonistas del GLP-1
Important factors to consider: Higher calorie and nutrient needs during breastfeeding Potential difficulty eating enough due to reduced appetite Limited safety data on infant exposure through breast milk Possible effects on maternal nutrition and milk production Breastfeeding requires additional calories and nutrients to support milk production and infant growth
For instance, individuals with undiagnosed sleep apnea may find that their quality of sleep is compromised, leading to daytime fatigue